158 related articles for article (PubMed ID: 23393013)
1. Good transfer of tebipenem into middle ear effusion conduces to the favorable clinical outcomes of tebipenem pivoxil in pediatric patients with acute otitis media.
Sugita R
J Infect Chemother; 2013 Jun; 19(3):465-71. PubMed ID: 23393013
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure.
Zielnik-Jurkiewicz B; Bielicka A
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2129-33. PubMed ID: 26454530
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a novel oral carbapenem, tebipenem pivoxil (TBM-PI), against experimental otitis media caused by penicillin resistant Streptococcus pneumoniae in chinchilla.
Hotomi M; Suzumoto M; Itahashi K; Nagura J; Fukushima T; Shimada J; Billal DS; Yamauchi K; Fujihara K; Yamanaka N
Vaccine; 2007 Mar; 25(13):2478-84. PubMed ID: 17055132
[TBL] [Abstract][Full Text] [Related]
4. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics.
Leibovitz E; Raiz S; Piglansky L; Greenberg D; Yagupsky P; Fliss DM; Leiberman A; Dagan R
Pediatr Infect Dis J; 1998 Jun; 17(6):463-9. PubMed ID: 9655535
[TBL] [Abstract][Full Text] [Related]
5. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen.
Leibovitz E; Greenberg D; Piglansky L; Raiz S; Porat N; Press J; Leiberman A; Dagan R
Pediatr Infect Dis J; 2003 Mar; 22(3):209-16. PubMed ID: 12634580
[TBL] [Abstract][Full Text] [Related]
6. [Tissue and aural discharge distribution of tebipenem pivoxil].
Baba S; Kasahara H; Morita J; Aizawa K; Sunakawa K
Jpn J Antibiot; 2009 Apr; 62(2):127-35. PubMed ID: 19673354
[TBL] [Abstract][Full Text] [Related]
7. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
Soriano F; Parra A; Cenjor C; Nieto E; García-Calvo G; Giménez MJ; Aguilar L; Ponte C
J Infect Dis; 2000 Feb; 181(2):646-52. PubMed ID: 10669350
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.
Figueira M; Fernandes P; Pelton SI
Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of tebipenem pivoxil treatment in children with pneumonia, who had no relief despite having administered oral beta-lactam antibiotics].
Sakata H
Jpn J Antibiot; 2011 Jun; 64(3):171-7. PubMed ID: 21861308
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of bacterial pathogens in otitis media with effusion.
Post JC; Preston RA; Aul JJ; Larkins-Pettigrew M; Rydquist-White J; Anderson KW; Wadowsky RM; Reagan DR; Walker ES; Kingsley LA; Magit AE; Ehrlich GD
JAMA; 1995 May 24-31; 273(20):1598-604. PubMed ID: 7745773
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Streptococcus pneumoniae and Haemophilus influenzae isolated from middle ear fluid before and after the introduction of government subsidies for pneumococcal and H. influenzae type b vaccines in Japan.
Hoshino T; Takeuchi N; Fukasawa C; Hirose S; Okui H; Sato H; Sato M; Arimoto Y; Nakano A; Ishiwada N
J Infect Chemother; 2017 Feb; 23(2):85-89. PubMed ID: 27889249
[TBL] [Abstract][Full Text] [Related]
13. Cytology of middle ear fluid during acute otitis media.
Broides A; Leibovitz E; Dagan R; Press J; Raiz S; Kafka M; Leiberman A; Yermiahu T
Pediatr Infect Dis J; 2002 Jan; 21(1):57-61. PubMed ID: 11791101
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antimicrobial treatments in children with acute otitis media in Spain: a pharmacokinetic-pharmacodynamic (PK/PD) approach.
Beobide I; Canut A; Gascón AR; Isla A; García-Rey C; De La Maza I; Labora A; Pedraz JL
J Chemother; 2005 Dec; 17(6):628-35. PubMed ID: 16433193
[TBL] [Abstract][Full Text] [Related]
15. Prediction of clinical bacteriological efficacy of oral antibiotics using a mechanism-based pharmacokinetic-pharmacodynamics modeling.
Matsumoto K; Sugano T; Sato N; Ida T; Shibasaki S
Jpn J Antibiot; 2014 Feb; 67(1):33-47. PubMed ID: 24809207
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of culture and real-time PCR methods in the detection of Streptococcus pneumoniae and Haemophilus influenzae in acute otitis media effusion specimens].
Eser OK; Alp S; Ergin A; Ipçi K; Alp A; Gür D; Hasçelik G
Mikrobiyol Bul; 2012 Oct; 46(4):676-81. PubMed ID: 23188581
[TBL] [Abstract][Full Text] [Related]
17. Complicated otitis media and its implications.
Leibovitz E
Vaccine; 2008 Dec; 26 Suppl 7():G16-9. PubMed ID: 19094932
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections].
Baba S; Yamanaka N; Suzuki K; Furukawa M; Furuya N; Ubukata K; Totsuka K
Jpn J Antibiot; 2009 Apr; 62(2):155-77. PubMed ID: 19673357
[TBL] [Abstract][Full Text] [Related]
19. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
Dagan R
Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial treatment of otitis media.
Giebink GS; Canafax DM
Semin Respir Infect; 1991 Jun; 6(2):85-93. PubMed ID: 1771307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
